Detection of mutated, free circulating tumor DNA in plasma of patients with resectable, stage I-IIIA non-small cell lung cancer

被引：0
|
作者：
Waldeck, S. [1 ]
Scherer, F. [1 ]
Philipp, U. [1 ]
Wiesemann, S. [2 ]
Andrieux, G. [3 ]
Boerries, M. [3 ]
Mitschke, J. [1 ]
Duyster, J. [1 ]
von Bubnoff, N. [1 ]
机构：
[1] Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany
[2] Univ Klinikum Freiburg, Abt Thoraxchirurg, Freiburg, Germany
[3] Univ Freiburg, Inst Mol Med & Zellforsch, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V471
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA detection in stage I non-small cell lung cancer patients by targeted sequencing.
    Chen, Kezhong
    Lou, Feng
    Yang, Fan
    Zhang, Jingbo
    Guan, Tian
    Wang, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Treatment of resectable stage IIIA non-small cell lung cancer
    Cardenal, Felipe
    Palmero, Ramon
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (01) : 13 - 15
  • [3] NeoCOAST: Neoadjuvant Durvalumab Alone or with Novel Agents for Resectable, Early-Stage (I-IIIA) Non-Small Cell Lung Cancer
    Garcia Campelo, R.
    Forde, P.
    Weder, W.
    Spicer, J.
    He, P.
    Hamid, O.
    Martinez, P.
    Cascone, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S719 - S719
  • [4] Real-life long-term outcomes of upfront surgery in patients with resectable stage I-IIIA non-small cell lung cancer
    Bitenc, Marko
    Cufer, Tanja
    Kern, Izidor
    Miklavcic, Martina
    Petrovic, Sabrina
    Groznik, Vida
    Sadikov, Aleksander
    [J]. RADIOLOGY AND ONCOLOGY, 2022, 56 (03) : 346 - 354
  • [5] Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer
    Li, Ning
    Wang, Bao-Xiao
    Li, Jian
    Shao, Yang
    Li, Ming-Tian
    Li, Jian-Jun
    Kuang, Peng-Peng
    Liu, Zui
    Sun, Tian-Yu
    Wu, Hui-Qi
    Ou, Wei
    Wang, Si-Yu
    [J]. CANCER, 2022, 128 (04) : 708 - 718
  • [6] Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning
    Zheng, Sunyi
    Guo, Jiapan
    Langendijk, Johannes A.
    Both, Stefan
    Veldhuis, Raymond N. J.
    Oudkerk, Matthijs
    van Ooijen, Peter M. A.
    Wijsman, Robin
    Sijtsema, Nanna M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 180
  • [7] p53 status and prognosis in stage I-IIIa non-small cell lung cancer
    Ohno, A
    Hirashima, T
    Kubo, A
    Masuda, N
    Takada, M
    Fujiwara, H
    Yasumitsu, T
    Kikui, M
    Fukuoka, M
    Nakagawa, K
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (03) : 521 - 528
  • [8] Cyclin A and Cyclin E Expression in Resected Non-small Cell Lung Cancer Stage I-IIIA
    Kosacka, Monika
    Piesiak, Pawel
    Porebska, Irena
    Korzeniewska, Anna
    Dyla, Tomasz
    Jankowska, Renata
    [J]. IN VIVO, 2009, 23 (04): : 519 - 525
  • [9] The expanding role of circulating tumor DNA in resectable non-small cell lung cancer
    Morgensztern, Daniel
    [J]. CANCER, 2024, 130 (10) : 1730 - 1732
  • [10] Circulating tumor DNA detection in advanced non-small cell lung cancer patients
    Guo, Zhi-Wei
    Li, Min
    Li, Ji-Qiang
    Zhou, Chun-Lian
    Zhai, Xiang-Ming
    Li, Ming
    Wu, Ying-Song
    Yang, Xue-Xi
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 878 - +
12345